MR Scanning of Very Young Children With Severe Developmental Disorders
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00156221 |
Recruitment Status
:
Completed
First Posted
: September 12, 2005
Last Update Posted
: September 12, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Autism Mental Retardation Language Disorder |
Study Type : | Observational |
Observational Model: | Natural History |
Time Perspective: | Cross-Sectional |
Time Perspective: | Retrospective/Prospective |
Official Title: | MR Scanning of Very Young Children With Severe Developmental Disorders (Autistic Spectrum Disorders and/or Mental Retardation and/or Language Disorders) |
Study Start Date : | September 2000 |
Study Completion Date : | September 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Months to 7 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18 months to 7 years
- Diagnosis of autism spectrum disorder, a language disorder or mental retardation
Exclusion Criteria:
- Significant motor or sensory impairment
- Major physical abnormalities
- History of serious head injury
- Identifiable neurologic disorder
- Metal implants
- Contraindication for MRI

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00156221
Netherlands | |
UMC Utrecht | |
Utrecht, Netherlands, 3508 GA |
Study Chair: | Herman van Engeland, PhD, MD | UMC Utrecht | |
Principal Investigator: | Mijke Zeegers, Msc | UMC Utrecht |
ClinicalTrials.gov Identifier: | NCT00156221 History of Changes |
Other Study ID Numbers: |
METC UMC Utrecht 99/184 |
First Posted: | September 12, 2005 Key Record Dates |
Last Update Posted: | September 12, 2005 |
Last Verified: | September 2005 |
Keywords provided by UMC Utrecht:
Autism MRI Developmental Disorders |
Additional relevant MeSH terms:
Language Disorders Disease Developmental Disabilities Intellectual Disability Pathologic Processes Neurodevelopmental Disorders |
Mental Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Signs and Symptoms Communication Disorders |